Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02955264 · ClinicalTrials.gov registry record · NA
Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation
A NA study, sponsored by Tulane University.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02955264: Completed NA study, sponsored by Tulane University.
NCT02955264 is a NA study that has completed, run by Tulane University. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02955264, a NA study, has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The goal of this study is to better characterize the metabolic alterations and sugar structure alterations (glycosylation abnormalities) in patients diagnosed with Congenital Disorders of Glycosylation. The investigators aim to assess the safety and tolerability of oral galactose treatment in a small pilot group of Congenital Disorders of Glycosylation patients. The investigators will also determine the relationship between simple milk sugar intake (galactose dose) in the diet and the blood and urine markers of protein glycosylation abnormalities.
Primary Outcome
Assess if the introduction of galactose into the subject's diet will normalization metabolic function. Metabolic function will be based on liver function and used for muscle enzyme tests, thyroid and growth hormone measurement, coagulation and anti-coagulation factors, blood sugar and milk-acid and biochemical/metabolic parameters. These measurements will be assessed together to see how many subjects will remain with abnormal values or change to within normal levels.
Interventions
- DIETARY_SUPPLEMENT D-Galactose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-01 |
| Phase | NA |
What the finished NCT02955264 record still lists
NCT02955264 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which D-Galactose is the first listed.
NCT02955264 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02955264 about?
NCT02955264 is a clinical study titled "Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation". The goal of this study is to better characterize the metabolic alterations and sugar structure alterations (glycosylation abnormalities) in patients diagnosed with Congenital Disorders of Glycosylation. The investigators aim to assess the safety and tolerability of oral galactose treatment in a smal...
What is the current status of trial NCT02955264?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2014-07. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02955264?
The interventions under investigation include: D-Galactose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02955264?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02955264's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia